Yong Xu

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 9

Top Topics

Molecular Docking

Chronic Obstructive Pulmonary Disease

Randomized Controlled Trial

Top Venues

Evidence-based complementary and alternative medicine : eCAM

Therapeutic advances in respiratory disease

BMJ open respiratory research

BioMed research international

This page only lists publications with an associated author ORCID identifier.

Publications

De-Yu Li, Xin Liu, Jing-Yi Huang, Wen-Lu Hang, Gu-Ran Yu, Yong Xu
Impact of antifibrotic therapy on disease progression, all-cause mortality, and risk of acute exacerbation in non-IPF fibrosing interstitial lung diseases: evidence from a meta-analysis of randomized controlled trials and prospective controlled studies. Therapeutic advances in respiratory disease 18 (2024)
De-Yu Li, Xin Liu, Jing-Yi Huang, Wen-Lu Hang, Gu-Ran Yu, Yong Xu
Impact of antifibrotic therapy on disease progression, all-cause mortality, and risk of acute exacerbation in non-IPF fibrosing interstitial lung diseases: evidence from a meta-analysis of randomized controlled trials and prospective controlled studies. Therapeutic advances in respiratory disease 18 (2024)
Hongzhen Lv, Jingyi Huang, Miao Miao, Cheng Huang, Wenlu Hang, Yong Xu
Could patients with chronic obstructive pulmonary disease benefit from renin angiotensin system inhibitors? A meta-analysis. BMJ open respiratory research 10 (1) (2023)
Hongzhen Lv, Jingyi Huang, Miao Miao, Cheng Huang, Wenlu Hang, Yong Xu
Could patients with chronic obstructive pulmonary disease benefit from renin angiotensin system inhibitors? A meta-analysis. BMJ open respiratory research 10 (1) (2023)
Wenpan Peng, Yong Xu, Yunhai Zhou, Juanjuan Wu, Guiqing Peng, Yanlan Gu, Xian-Mei Zhou, Mingzhi Pu
Sanzi Yangqin Decoction Alleviates Allergic Asthma by Modulating Th1/Th2 Balance: Coupling Network Pharmacology with Biochemical Pharmacology. Evidence-based complementary and alternative medicine : eCAM 2022 (2022)
Wenpan Peng, Yong Xu, Fanchao Feng, Cheng Gu, Zhichao Wang, Di Han, Xian-Mei Zhou, Hai-Lang He
Meta-Analysis of Therapy of Cinobufacini Capsule Adjunct with First-Line Platinum-Based Chemotherapy for the Treatment of Advanced NSCLC. Evidence-based complementary and alternative medicine : eCAM 2021 (2021)
Yong Xu, Wenpan Peng, Di Han, Zhichao Wang, Fanchao Feng, Xian-Mei Zhou, Qi Wu
Material Basis and Mechanism of Chansu Injection for COVID-19 Treatment Based on Network Pharmacology and Molecular Docking Technology. Evidence-based complementary and alternative medicine : eCAM 2021 (2021)
Qi Wu, Yong Xu, Ke-Jia Zhang, Shi-Min Jiang, Yao Zhou, Ying Zhao
A Clinical Model for the Prediction of Acute Exacerbation Risk in Patients with Idiopathic Pulmonary Fibrosis. BioMed research international 2020 (2020)
Cheng Gu, Wenpan Peng, Zhichao Wang, Yong Xu, Di Han, Xian-Mei Zhou
Suhuang Zhike Capsules for the Treatment of Cough Variant Asthma: A Meta-analysis. Evidence-based complementary and alternative medicine : eCAM 2020 (2020)